In SURMOUNT-1, approximately 4.3-7.1% of participants discontinued due to side effects (dose-dependent), compared to 6.4% with liraglutide in the SCALE trials
El estudio tambin encontr "mejoras incluso mayores en los sntomas relacionados con la insuficiencia cardiaca y las limitaciones fsicas en los que tenan FA frente a las que no lo tenan, aunque se observaron mejoras en ambos grupos", segn el comunicado de prensa
The populations were matched by sex, height, weight, race, ethnicity, social vulnerability index (SVI), and age
The guidelines below are for general educational purposes
PubMed laboratory research record [PMID: 11376200] PubMed record related to this compound for laboratory literature review
When we begin with you, youre like a blank canvas